These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 2784379)

  • 21. Enhancement of interleukin-2 (IL-2) production by 6 different cytokines: heterogeneity among IL-2 producing T cell clones.
    Holán V; Minowada J
    Folia Biol (Praha); 1993; 39(1):1-13. PubMed ID: 8348981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accessory function of human fibroblasts in mitogen-stimulated interferon-gamma production by T lymphocytes. Inhibition by interleukin 1 and tumor necrosis factor.
    Le JM; Vilcek J
    J Immunol; 1987 Nov; 139(10):3330-7. PubMed ID: 3119705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ia-restricted interaction of normal lymphoid cells and SJL lymphoma (reticulum cell sarcoma) leading to lymphokine production. III. Relative roles of reticulum cell sarcoma and normal lymphoid cells in lymphokine production.
    Hayama T; Ponzio NM; Nagler C; Vilcek J; Coico RF; Thorbecke GJ
    J Natl Cancer Inst; 1984 Feb; 72(2):321-31. PubMed ID: 6420600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of receptors for interleukin 2: Role in the commitment of T lymphocytes to proliferate.
    Lipkowitz S; Greene WC; Rubin AL; Novogrodsky A; Stenzel KH
    J Immunol; 1984 Jan; 132(1):31-7. PubMed ID: 6418801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigen-induced human interferon-gamma production. Differential dependence on interleukin 2 and its receptor.
    Kelly CD; Welte K; Murray HW
    J Immunol; 1987 Oct; 139(7):2325-8. PubMed ID: 2958545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The suppressive effect of Tripterygium wilfordii hook F on the IL-2 autocrine loop of human T cells].
    Dong Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Jun; 15(3):193-6. PubMed ID: 8222004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of in vivo-activated allospecific T lymphocytes propagated from human renal allograft biopsies undergoing rejection.
    Mayer TG; Fuller AA; Fuller TC; Lazarovits AI; Boyle LA; Kurnick JT
    J Immunol; 1985 Jan; 134(1):258-64. PubMed ID: 3155462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human bone marrow allograft recipients: production of, and responsiveness to, interleukin 2.
    Warren HS; Atkinson K; Pembrey RG; Biggs JC
    J Immunol; 1983 Oct; 131(4):1771-5. PubMed ID: 6352802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complex effects of interferon-alpha on the cytokine network in HIV infection--possible contribution to immunosuppression.
    Stylianou E; Aukrust P; Müller F; Nordøy I; Frøland SS
    Cytokine; 2001 Apr; 14(1):56-62. PubMed ID: 11298493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-12 synergizes with IL-2 and other stimuli in inducing IL-10 production by human T cells.
    Jeannin P; Delneste Y; Seveso M; Life P; Bonnefoy JY
    J Immunol; 1996 May; 156(9):3159-65. PubMed ID: 8617936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro effects of gold sodium thiomalate on IL-1, IL-2 production, IL-2 receptor expression and IL-2 responsiveness in thymocytes and peripheral blood mononuclear cells.
    Blitstein-Willinger E; Streller A
    Clin Exp Immunol; 1987 May; 68(2):357-65. PubMed ID: 3115645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-2 in rheumatoid arthritis: production of and response to interleukin-2 in rheumatoid synovial fluid, synovial tissue and peripheral blood.
    Combe B; Pope RM; Fischbach M; Darnell B; Baron S; Talal N
    Clin Exp Immunol; 1985 Mar; 59(3):520-8. PubMed ID: 3921298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production of interleukin 2 in multiple myeloma.
    Commes T; Klein B; Jourdan M; Bataille R
    Clin Exp Immunol; 1986 Mar; 63(3):533-40. PubMed ID: 3486731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin 2 defect in the peripheral blood and the lung in patients with Sjögren's syndrome.
    Miyasaka N; Murota N; Yamaoka K; Sato K; Yamada T; Nishido T; Okuda M
    Clin Exp Immunol; 1986 Sep; 65(3):497-505. PubMed ID: 3490935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Biological effects of interleukin-2 and prospects for its use in the immunotherapy of malignant neoplasms].
    Berezhnaia NM; Goretskiĭ BA
    Eksp Onkol; 1989; 11(6):38-44. PubMed ID: 2684609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clear cell sarcoma and selective IgM deficiency: a case report.
    Vogelzang NJ; Corwin H; Finlay JL; Pellettiere EV; Luskin AT; Di Camelli RF; Hong R
    Cancer; 1982 Jan; 49(2):234-8. PubMed ID: 7053825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thymus-dependent and nonthymus-dependent lymphocytes in patients with sarcomas.
    Pritchard DJ; Miller GC; Ritts RE; Ivins JC
    Cancer; 1977 Aug; 40(2):803-7. PubMed ID: 302142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of serum immunity on a human sarcoma in rats].
    BUTTLE GA; KOVACS EM
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1960; 238():94-6. PubMed ID: 13849254
    [No Abstract]   [Full Text] [Related]  

  • 39. Production of serum from small amounts of blood.
    HARBOE N
    Scand J Clin Lab Invest; 1956; 8(1):71-2. PubMed ID: 13337128
    [No Abstract]   [Full Text] [Related]  

  • 40. [Modifying effect of the blood serum from patients with soft-tissue sarcomas on interleukin-2 production and activity].
    Goretskiĭ BA; Berezhnaia NM; Palivets AIu; Konovalenko VF
    Eksp Onkol; 1989; 11(1):59-61. PubMed ID: 2784379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.